CDCA2 and COVID-19: This study, through bioinformatics and module pharmacology analysis, identified immune‐related subgroup biomarkers—CEP55, CDCA2, MELK, and DEPDC1B—associated with the progression from COVID‐19 to long COVID and preliminarily explained the immune‐related mechanisms of this transition.